NCT04122469View on ClinicalTrials.gov

The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease

NARecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

September 11, 2019

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
MalignancyBreast Cancer MetastaticGenito-urinary
Interventions
RADIATION

Stereotactic Body Radiotherapy

The purpose of this study is to evaluate the safety, and efficacy of SBRT in this patient population

Trial Locations (1)

M5G 2M9

RECRUITING

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER